Raising the question of the potential impact of MD on women with a germline mutation in BRCA1 and BRCA2 genes, Mitchell et al. evaluated the association between MD and BC risk among 342 women from the EMBRACE study, 206 of whom were BRCA mutation carriers [17]. The gene discussed is BRCA1; the disease is breast cancer.